VAERS reports by lot

GSK Varicella/Shingles lot 2N9CT: VAERS reports

23 VAERS reports list lot 2N9CT as a GSK Varicella/Shingles vaccine, received between 2020-01-28 and 2021-10-04. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
23
Reports
4%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2124%
General / Systemic (non-local)1720%
Neurological1315%
Dermatological (non-injection-site)1011%
Musculoskeletal89%
Gastrointestinal67%
Cardiac / Cardiovascular45%
Allergic / Anaphylactic45%
Autoimmune / Immune-mediated33%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Pennsylvania4
Missouri3
South Carolina2
Texas2
Indiana2
Florida2
Wisconsin1
Arkansas1
Georgia1
Tennessee1
Kansas1
Nebraska1

Reports by month received

2020-011
2020-027
2020-035
2020-041
2020-052
2020-062
2020-071
2020-081
2020-091
2020-101
2021-101

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.